Navana Pharmaceuticals PLC
73.60
BDT
+0.80
+1.10%
Last updated on 15 Jul, 14:11
Today
1.10%
1 Week
1.94%
1 Month
2.36%
6 Month
41.81%
1 Year
40.19%
5 Year
-
Matket Today
Open
72.9
BDT
Low
72.8
BDT
High
74.8
BDT
Volume
1205724
Value
8.90
Crore
Trade
1942
YCP
72.8
BDT
52W Low
45.5
BDT
52W High
78
BDT
Circuit Low
65.6
BDT
Circuit Up
80
BDT
Beta (1 Year)
1.35
Financial Indicators
P/E ratio
12.11
EPS (TTM)
6.08
NAV (Q3 2026)
49.53
Total Shares
10.74
Crore
Shot-term loan
5.18
Crore
Long-term loan
1.10
Crore
Market Capital
781.99
Crore
Paid-up Capital
107.42
Crore
Authorized Capital
200
Crore
Last AGM Date
31 Dec 2025
Last Record Date
19 Nov 2025
Year End
30-Jun
About Navana Pharmaceuticals PLC
Sector
Pharmaceuticals & Chemicals
Listing Year
2022
cs@navanapharma.com
Navana Pharmaceuticals Ltd. (NPL) has been expanding its business since 1992, emphasizing innovation and quality products. The company operates in Veterinary and Human Health divisions, manufacturing high-quality veterinary medicine and pharmaceutical products under strict compliance with WHO cGMP guidelines. NPL prioritizes people quality, process development, and utilizes ICT. Adhering to WHO cGMP and QMS principles, the company focuses on built-in quality at every stage. NPL is growing in both domestic and international markets, showcasing its commitment to excellence in the pharmaceutical industry.